Opko Health traded at $2.97 this Wednesday May 18th, decreasing $0.13 or 4.19 percent since the previous trading session. Looking back, over the last four weeks, Opko Health lost 6.31 percent. Over the last 12 months, its price fell by 17.73 percent. Looking ahead, we forecast Opko Health to be priced at 2.84 by the end of this quarter and at 2.64 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
2.97
Daily Change
-4.19%
Yearly
-17.73%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abbott 113.52 -1.02 -0.89% -2.46%
Acadia Pharmaceuticals 16.20 -0.85 -4.99% -21.81%
Acorda Therapeutics 0.57 -0.09 -13.53% -86.06%
Agios Pharmaceuticals 21.59 -0.74 -3.31% -60.82%
Akebia Therapeutics 0.36 -0.01 -2.03% -89.40%
ALKERMES 29.39 -0.30 -1.01% 34.32%
Alnylam Pharmaceuticals 129.33 0.02 0.02% -4.15%
Amarin 1.49 -0.18 -10.54% -67.00%
Ardelyx 0.68 -0.02 -2.20% -90.06%
Arrowhead Research 34.58 -1.19 -3.33% -51.58%
Bluebird Bio 3.36 -0.26 -7.18% -88.58%
BioMarin Pharmaceutical 78.90 -0.22 -0.28% 3.25%
Bristol-Myers Squibb 77.09 -1.13 -1.44% 17.60%
Coherus Biosciences 7.49 -0.42 -5.31% -45.01%
Quest Diagnostics 138.76 -1.76 -1.25% 6.17%
Emergent BioSolutions 29.19 -0.48 -1.62% -49.87%
Esperion Therapeutics 6.38 -0.14 -2.15% -68.73%
Exact Sciences 53.00 -1.11 -2.05% -45.12%
Exelixis 20.50 -0.19 -0.92% -15.78%
Halozyme Therapeutics 44.21 -0.26 -0.57% 4.36%
Intercept Pharmaceuticals 18.08 -0.74 -3.93% 6.42%
Insmed 21.01 -0.49 -2.28% -19.35%
Ionis Pharmaceuticals 38.50 -0.26 -0.66% 4.41%
Ironwood Pharmaceuticals 11.67 0.02 0.17% -2.75%
Laboratory Of America 243.51 -4.24 -1.71% -8.81%
Lexicon Pharmaceuticals 1.67 -0.08 -4.31% -61.19%
Moderna Inc 137.23 -5.05 -3.55% -13.14%
Myriad Genetics 21.75 -0.90 -3.97% -19.05%
Neurocrine Biosciences 85.71 -0.09 -0.10% -8.63%
Opko Health 2.97 -0.13 -4.19% -17.73%
Puma Biotechnology 1.99 -0.01 -0.50% -80.41%
PTC Therapeutics 31.16 -0.69 -2.17% -18.54%
Ultragenyx Pharmaceutical 51.67 -2.68 -4.93% -53.63%
Seattle Genetics 143.70 -2.85 -1.94% -3.06%
Sarepta Therapeutics 69.61 -1.69 -2.37% -9.50%
Teva Pharmaceutical Industries 8.40 0 0% -21.27%
United Therapeutics 190.50 -0.49 -0.26% -2.62%
Vanda Pharmaceuticals 9.83 -0.19 -1.85% -46.31%

Indexes Price Day Year
US2000 1769 -70.89 -3.85% -19.34%

Opko Health
OPKO Health, Inc. is a healthcare company. Its segments include Diagnostics and Pharmaceutical. The Pharmaceutical segment consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain. The Diagnostics segment consists of the clinical laboratory operations of Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations. Through Bio-Reference, it operates laboratory divisions, such as Bio-Reference, GenPath (Oncology), GenPath (Women's Health) and GeneDx. Its Pharmaceutical Business have one commercial stage pharmaceutical product and several pharmaceutical compounds and technologies in various stages of research and development for a range of indications and conditions, including Renal Products, Oxyntomodulin, Biologics, Factor VIIa -CTP, hGH-CTP. It also owns an active pharmaceutical ingredients (APIs) manufacturer in Israel through its subsidiary FineTech Pharmaceutical, Ltd.